Status:
COMPLETED
Enhanced Recovery in Laparoscopic Cholecystectomy
Lead Sponsor:
Pirogov Russian National Research Medical University
Conditions:
Acute Cholecystitis
Gangrenous Cholecystitis
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The study assesses the impact of the modified enhanced recovery protocol on the results of surgical treatment of patients with acute cholecystitis.
Detailed Description
Laparoscopic cholecystectomy (LC) is the most common surgical procedures in the world. Elective LC is commonly performed as one-day surgery, while in an emergency setting of acute cholecystitis the in...
Eligibility Criteria
Inclusion
- Grade I and II acute cholecystitis according to Tokyo Guidelines 2013 classification (TG13)
- ASA I and II.
Exclusion
- Severe acute cholecystitis (Grade III on TG13);
- Patient's refusal to participate;
- The language barrier;
- Transfer to the intensive care unit after surgery;
- ASA class ≥ III;
- Conversion to open procedure;
- Biliary hypertension detected during preoperative examination or intraoperatively.
Key Trial Info
Start Date :
January 31 2017
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 30 2019
Estimated Enrollment :
189 Patients enrolled
Trial Details
Trial ID
NCT03754751
Start Date
January 31 2017
End Date
January 30 2019
Last Update
January 15 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Taras Nechay
Moscow, Russia, 115569